Novelix Pharmaceuticals Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Novelix Pharmaceuticals Inc.
Start-Up Previews (3/06)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Cardiac Regeneration Start-Ups Look to Repair, not Replace, features profiles of Arteriocyte, Celladon, NanoCor Therapeutics and Theregen. Plus these Start-Up Across Health Care: Alder Biopharmaceuticals, Endotis, Novelix and VaxInnate.
Novelix Pharmaceuticals Inc.
For 15 years, its founders dreamed of starting a company to design new cancer drugs, but it wasn't until 2005 that they were able to lock up all the compounds they wanted. Novelix Pharmaceuticals now boasts a preclinical pipeline that's four candidates strong--all novel, proprietary, small molecules with innovative modes of action and favorable ADMET profiles.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice